
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions β written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Minimal change disease history and symptoms
Introduction
Overview
Overview
The hallmark of minimal change disease in children is acute-onset proteinuria that progresses into nephrotic syndrome. Fatigue and subsequent edema develops with symptoms of periorbital edema and weight gain. Children are less likely to present with other clinical features, such as hypertension, renal failure, or hematuria. In contrast, adults are more likely to present with hypertension in approximately 40% of cases, and hematuria in approximately 30% of cases. A reduced estimated glomerular filtration rate (eGFR) at presentation is also not uncommon. Finally,Β upper respiratory tract infection, such as pneumonia in an otherwise healthy individual, may be the first sign of nephrotic syndrome in minimal change disease.
History and Symptoms
History and Symptoms
The hallmark of minimal change disease is proteinuria.[1]
History
Patients with minimal change disease may have a positive history of:[2][3][4]
- Upper respiratory tract infection.
- Infections such as
- Diarrhea
Common Symptoms
Common symptoms of minimal change disease include:[5][6][7][8]
- Fatigue
- Edema: periorbital edema, weight gain[9]
- Hypertension
- Hematuria[9][10]
- Symptoms of infections, such as pneumonia[9]
- Irritability
- Headache
Less Common Symptoms
Less common symptoms of minimal change disease include[11][12][13]
- Thromboembolism[14]
- Cardiovascular disease
- Thyroid dysfunction
- Hypocalcemia
- Hypovitaminosis D[10]
References
References
- β Vivarelli M, Massella L, Ruggiero B, Emma F (February 2017). “Minimal Change Disease”. Clin J Am Soc Nephrol. 12 (2): 332β345. doi:10.2215/CJN.05000516. PMCΒ 5293332. PMIDΒ 27940460.
- β Vivarelli, Marina; Massella, Laura; Ruggiero, Barbara; Emma, Francesco (2017). “Minimal Change Disease”. Clinical Journal of the American Society of Nephrology. 12 (2): 332β345. doi:10.2215/CJN.05000516. ISSNΒ 1555-9041.
- β Waldman M, Crew RJ, Valeri A, Busch J, Stokes B, Markowitz G, D’Agati V, Appel G (May 2007). “Adult minimal-change disease: clinical characteristics, treatment, and outcomes”. Clin J Am Soc Nephrol. 2 (3): 445β53. doi:10.2215/CJN.03531006. PMIDΒ 17699450.
- β Rheault MN, Zhang L, Selewski DT, Kallash M, Tran CL, Seamon M, Katsoufis C, Ashoor I, Hernandez J, Supe-Markovina K, D’Alessandri-Silva C, DeJesus-Gonzalez N, Vasylyeva TL, Formeck C, Woll C, Gbadegesin R, Geier P, Devarajan P, Carpenter SL, Kerlin BA, Smoyer WE (December 2015). “AKI in Children Hospitalized with Nephrotic Syndrome”. Clin J Am Soc Nephrol. 10 (12): 2110β8. doi:10.2215/CJN.06620615. PMCΒ 4670770. PMIDΒ 26450933.
- β Vivarelli M, Massella L, Ruggiero B, Emma F (February 2017). “Minimal Change Disease”. Clin J Am Soc Nephrol. 12 (2): 332β345. doi:10.2215/CJN.05000516. PMCΒ 5293332. PMIDΒ 27940460.
- β Vivarelli, Marina; Massella, Laura; Ruggiero, Barbara; Emma, Francesco (2017). “Minimal Change Disease”. Clinical Journal of the American Society of Nephrology. 12 (2): 332β345. doi:10.2215/CJN.05000516. ISSNΒ 1555-9041.
- β Waldman M, Crew RJ, Valeri A, Busch J, Stokes B, Markowitz G, D’Agati V, Appel G (May 2007). “Adult minimal-change disease: clinical characteristics, treatment, and outcomes”. Clin J Am Soc Nephrol. 2 (3): 445β53. doi:10.2215/CJN.03531006. PMIDΒ 17699450.
- β Rheault MN, Zhang L, Selewski DT, Kallash M, Tran CL, Seamon M, Katsoufis C, Ashoor I, Hernandez J, Supe-Markovina K, D’Alessandri-Silva C, DeJesus-Gonzalez N, Vasylyeva TL, Formeck C, Woll C, Gbadegesin R, Geier P, Devarajan P, Carpenter SL, Kerlin BA, Smoyer WE (December 2015). “AKI in Children Hospitalized with Nephrotic Syndrome”. Clin J Am Soc Nephrol. 10 (12): 2110β8. doi:10.2215/CJN.06620615. PMCΒ 4670770. PMIDΒ 26450933.
- β 9.0 9.1 9.2 Waldman M, Crew RJ, Valeri A, Busch J, Stokes B, Markowitz G; et al. (2007). “Adult minimal-change disease: clinical characteristics, treatment, and outcomes”. Clin J Am Soc Nephrol. 2 (3): 445β53. doi:10.2215/CJN.03531006. PMIDΒ 17699450.
- β 10.0 10.1 Saha TC, Singh H (2006). “Minimal change disease: a review”. South Med J. 99 (11): 1264β70. PMIDΒ 17195422.
- β Vivarelli, Marina; Massella, Laura; Ruggiero, Barbara; Emma, Francesco (2017). “Minimal Change Disease”. Clinical Journal of the American Society of Nephrology. 12 (2): 332β345. doi:10.2215/CJN.05000516. ISSNΒ 1555-9041.
- β Waldman M, Crew RJ, Valeri A, Busch J, Stokes B, Markowitz G, D’Agati V, Appel G (May 2007). “Adult minimal-change disease: clinical characteristics, treatment, and outcomes”. Clin J Am Soc Nephrol. 2 (3): 445β53. doi:10.2215/CJN.03531006. PMIDΒ 17699450.
- β Rheault MN, Zhang L, Selewski DT, Kallash M, Tran CL, Seamon M, Katsoufis C, Ashoor I, Hernandez J, Supe-Markovina K, D’Alessandri-Silva C, DeJesus-Gonzalez N, Vasylyeva TL, Formeck C, Woll C, Gbadegesin R, Geier P, Devarajan P, Carpenter SL, Kerlin BA, Smoyer WE (December 2015). “AKI in Children Hospitalized with Nephrotic Syndrome”. Clin J Am Soc Nephrol. 10 (12): 2110β8. doi:10.2215/CJN.06620615. PMCΒ 4670770. PMIDΒ 26450933.
- β Kerlin BA, Ayoob R, Smoyer WE (March 2012). “Epidemiology and pathophysiology of nephrotic syndrome-associated thromboembolic disease”. Clin J Am Soc Nephrol. 7 (3): 513β20. doi:10.2215/CJN.10131011. PMCΒ 3302669. PMIDΒ 22344511.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Yazan Daaboul, Vamsikrishna Gunnam M.B.B.S [2]
